| __timestamp | Incyte Corporation | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 347523000 | 14182353 |
| Thursday, January 1, 2015 | 479514000 | 15503028 |
| Friday, January 1, 2016 | 581861000 | 16183585 |
| Sunday, January 1, 2017 | 1326361000 | 22382849 |
| Monday, January 1, 2018 | 1197957000 | 33038206 |
| Tuesday, January 1, 2019 | 1154111000 | 31777040 |
| Wednesday, January 1, 2020 | 2215942000 | 41464134 |
| Friday, January 1, 2021 | 1458179000 | 67178053 |
| Saturday, January 1, 2022 | 1585936000 | 52531000 |
| Sunday, January 1, 2023 | 1627594000 | 68914000 |
| Monday, January 1, 2024 | 2606848000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, innovation is the key to success. Over the past decade, Incyte Corporation and Pharming Group N.V. have been at the forefront of this race, investing heavily in research and development (R&D). From 2014 to 2023, Incyte Corporation has consistently outpaced Pharming Group N.V. in R&D spending. Incyte's investment grew from approximately $348 million in 2014 to over $1.6 billion in 2023, marking a staggering 367% increase. In contrast, Pharming Group N.V. increased its R&D expenses from around $14 million to nearly $69 million, a 388% rise, albeit from a much smaller base. This data highlights the significant commitment of both companies to innovation, with Incyte leading the charge in absolute terms. As the biotech industry continues to evolve, these investments could be pivotal in shaping the future of healthcare.
Research and Development: Comparing Key Metrics for Gilead Sciences, Inc. and Pharming Group N.V.
GSK plc vs Pharming Group N.V.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Genmab A/S vs Incyte Corporation
Research and Development Expenses Breakdown: Incyte Corporation vs Ascendis Pharma A/S
Incyte Corporation vs Viking Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and Veracyte, Inc.
Incyte Corporation or HUTCHMED (China) Limited: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Incyte Corporation and Viridian Therapeutics, Inc.
Pharming Group N.V. vs Opthea Limited: Strategic Focus on R&D Spending
Pharming Group N.V. or Verona Pharma plc: Who Invests More in Innovation?
Pharming Group N.V. or Protagonist Therapeutics, Inc.: Who Invests More in Innovation?
Pharming Group N.V. or Viridian Therapeutics, Inc.: Who Invests More in Innovation?